Paid Clinical Trials in Ohio

Ohio has 3,475 paid clinical trials enrolling now across cities including Columbus, Cleveland and Cincinnati. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Ohio include Cleveland Clinic, Ohio State Wexner Medical Center and Cincinnati Children's, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

3,475 clinical trials

↓ Download CSV

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

for Colorectal Cancer Stage II

376 locations incl. Anchorage

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07018869·Phase 3·Recruiting

Apply to this trial

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for Metabolic Dysfunction-Associated Steatotic Liver Disease

140 locations incl. Tuscaloosa

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07165028·Phase 3·Recruiting

Apply to this trial

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

for Alcohol Use Disorder

Drug: Brenipatide

30 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07219966·Phase 3·Recruiting

Apply to this trial

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for Chronic Lymphocytic Leukemia (CLL)

13 locations incl. Duarte

Sponsor: Nurix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07221500·Phase 2·Recruiting

Apply to this trial

Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.

for Persistent Spinal Pain Syndrome

1 location in Cleveland

Sponsor: University Hospitals Cleveland Medical Center

Sex: All·Age: 30+

Code: NCT07091123·Phase 4·Recruiting

Apply to this trial

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

for Angelman Syndrome

8 locations incl. Los Angeles

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All·Age: 1 - 64

Code: NCT07157254·Phase 2·Recruiting

Apply to this trial

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

8 locations incl. Phoenix

Sponsor: City of Hope Medical Center

Sex: All·Age: 18 - 54

Code: NCT06918431·Phase 2·Recruiting

Apply to this trial

Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

for COPD

1 location in Cleveland

Sponsor: The Cleveland Clinic

Sex: All·Age: 40+

Code: NCT07059637·Recruiting

Apply to this trial

BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation

for Physical Fitness

3 locations incl. Columbus

Sponsor: MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07256717·Recruiting

Apply to this trial

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for PIK3CA-related Overgrowth Spectrum (PROS)

4 locations incl. St Louis

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 100

Code: NCT06997588·Phase 2·Recruiting

Apply to this trial

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

for Shigella

1 location in Cincinnati

Sponsor: Inventprise Inc.

Sex: All·Age: 18 - 49·Accepts healthy volunteers

Code: NCT07205926·Phase 1·Recruiting

Apply to this trial

FebriDx® Pediatric Validation Study

for Acute Respiratory Infections (ARIs)

10 locations incl. Colton

Sponsor: Lumos Diagnostics

Sex: All·Age: 2 - 11

Code: NCT07211997·Recruiting

Apply to this trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

Drug: Duvakitug

91 locations incl. Peoria

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184996·Phase 3·Recruiting

Apply to this trial

Fluid Guided Heart Failure Treatment at the Cleveland Clinic

for Heart Failure

1 location in Cleveland

Sponsor: Bodyport Inc.

Sex: All·Age: 21+

Code: NCT07205120·Recruiting

Apply to this trial

LT Comparative Effectiveness of 2 Caries Treatments

for Dental Caries

1 location in Cleveland

Sponsor: Case Western Reserve University

Sex: All·Age: 62+·Accepts healthy volunteers

Code: NCT07213661·Recruiting

Apply to this trial

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

for Head and Neck Cancer

1 location in Cincinnati

Sponsor: University of Cincinnati

Sex: All·Age: 18+

Code: NCT07213934·Phase 1, Phase 2·Recruiting

Apply to this trial

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

83 locations incl. Tucson

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06649812·Phase 2·Recruiting

Apply to this trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for Muscle Invasive Bladder Urothelial Carcinoma

211 locations incl. Fort Smith

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT07097142·Phase 3·Recruiting

Apply to this trial

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

6 locations incl. San Francisco

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07140900·Phase 1·Recruiting

Apply to this trial

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

for Proteinuria

Drug: Sparsentan

9 locations incl. Birmingham

Sponsor: Travere Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07219121·Phase 4·Recruiting

Apply to this trial

Central Vein Sign in Multiple Sclerosis Extension Study

for Multiple Sclerosis

3 locations incl. Los Angeles

Sponsor: The Cleveland Clinic

Sex: All·Age: 18 - 65

Code: NCT07424027·Recruiting

Apply to this trial

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

for Colorectal Adenomatous Polyp

5 locations incl. Ann Arbor

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05630794·Phase 1·Recruiting

Apply to this trial

Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation

for Adjustment Disorders

3 locations incl. San Diego

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 64

Code: NCT06885554·Recruiting

Apply to this trial

AtorvaStatin Postpartum and Reduction of Cardiovascular risK

for Hypertensive Disorders of Pregnancy

1 location in Columbus

Sponsor: Ohio State University

Sex: Female·Age: 20 - 50

Code: NCT06632379·Phase 4·Recruiting

Apply to this trial

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

for Chemotherapy Induced Peripheral Neuropathy (CIPN)

17 locations incl. Poway

Sponsor: Luminate Medical, Inc.

Sex: All·Age: 18+

Code: NCT07142304·Recruiting

Apply to this trial

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

for Multiple Myeloma

5 locations incl. San Francisco

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18 - 80

Code: NCT07149857·Phase 2·Recruiting

Apply to this trial

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for Crohn Disease

58 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07196722·Phase 2, Phase 3·Recruiting

Apply to this trial

Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

for Nonfluent Variant Primary Progressive Aphasia (nfvPPA)

5 locations incl. Chicago

Sponsor: EIP Pharma Inc

Sex: All·Age: 40 - 85

Code: NCT07033481·Phase 2·Recruiting

Apply to this trial

Safety of RSV Preventive Monoclonal Antibody

for Fever

6 locations incl. Oakland

Sponsor: Duke University

Sex: All·Age: 6 Weeks - 30 Weeks·Accepts healthy volunteers

Code: NCT07158814·Phase 4·Recruiting

Apply to this trial

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Drug: Coramitug

61 locations incl. Phoenix

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07207811·Phase 3·Recruiting

Apply to this trial

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for NSCLC Stage IV

19 locations incl. Springdale

Sponsor: ImmunityBio, Inc.

Sex: All·Age: 18 - 90

Code: NCT06745908·Phase 3·Recruiting

Apply to this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

for Recurrent Glioblastoma

1 location in Columbus

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18 - 85

Code: NCT06910306·Recruiting

Apply to this trial

Optimal Ventilation for Cardiac Arrest

for Cardiac Arrest (CA)

20 locations incl. Orange

Sponsor: Children's Hospital of Philadelphia

Sex: All·Age: 37 Weeks - 18

Code: NCT07114510·Recruiting

Apply to this trial

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

for Locoregionally Recurrent Hormone-receptor Positive Breast Cancer

6 locations incl. Indianapolis

Sponsor: Radionetics Oncology

Sex: All·Age: 18+

Code: NCT07121244·Phase 1·Recruiting

Apply to this trial

Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity

for Adequate Vitamin C Status

1 location in Columbus

Sponsor: Ohio State University

Sex: All·Age: 18 - 50

Code: NCT07151105·Recruiting

Apply to this trial

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

for Pulmonary Arterial Hypertension (PAH)

10 locations incl. Phoenix

Sponsor: AllRock Bio, Inc.

Sex: All·Age: 18+

Code: NCT07175038·Phase 2·Recruiting

Apply to this trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Duvakitug

93 locations incl. Peoria

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184931·Phase 3·Recruiting

Apply to this trial

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for Colitis, Ulcerative

54 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 12+

Code: NCT07196748·Phase 3·Recruiting

Apply to this trial

A Long-Term Study of Navenibart in Participants With Hereditary Angioedema

for Hereditary Angioedema (HAE)

Drug: navenibart

10 locations incl. Scottsdale

Sponsor: Astria Therapeutics, Inc.

Sex: All·Age: 12+

Code: NCT07204938·Phase 3·Enrolling By Invitation

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

for Diabetes Mellitus, Type 2

3 locations incl. Stanford

Sponsor: Stanford University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06251323·Recruiting

Apply to this trial